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A patient diagnosed with a glioma generally has an average of 14 months
to live after implementation of conventional therapies such as surgery,
chemotherapy, and radiation. Glioblastomas are highly lethal because of their
aggressive nature and resistance to conventional therapies and apoptosis. Thus
other avenues of cell death urgently need to be explored. Autophagy, which is
also known as programmed cell death type II, has recently been identified as an
alternative mechanism to kill apoptosis-resistant cancer cells. Traditionally,
researchers have studied how cells undergo autophagy during viral infection as
an immune response mechanism, but recently researchers have discovered how
viruses have evolved to manipulate autophagy for their benefit. Extensive studies
of viral-induced autophagy provide a rationale to investigate other viruses, such
as the adenovirus, which may be developed as part of a therapy against cancers
resistant to apoptosis. Despite the present and relatively poor understanding of
the mechanisms behind adenoviral-induced autophagy, adenovirus is a
promising candidate, because of its ability to efficiently eradicate tumors. A better
understanding of how the adenovirus induces autophagy will allow for the
development of viruses with increased oncolytic potency. We hypothesized that
adenovirus induces autophagy in order to aid in lysis. We found that replication,
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not infection, was required for adenovirus-mediated autophagy. Loss of function
analysis of early genes revealed that, of the early genes tested, no single gene
alone was sufficient to induce autophagy. Examination of cellular pathways for
their role in autophagy during adenovirus infection revealed a function for the
eIF2α pathway and more specifically the GCN2 kinase. Cells lacking GCN2 are
more resistant to adenovirus-mediated autophagy in vitro; in vivo we also found
these cells fail to undergo autophagy, but display more cell death. We believe
that autophagy is a protective mechanism the cell employs during adenoviral
infection, and in the in vivo environment, cells cannot recover from virus infection
and are more susceptible to death.

Congruently, infected cells deficient for

autophagy through deletion of ATG5 are not able to undergo productive cell lysis,
providing evidence that the destruction of the cytoplasm and cell membrane
through autophagy is crucial to the viral life cycle. This project is the first to
describe a gene, other than a named autophagy gene, to be required for
adenovirus-mediated autophagy. It is also the first to examine autophagic cell
death as a means to aid in viral-induced cell lysis.
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Chapter One: Introduction

The tribulations of glioma therapy
While there have been many advancements in some cancers, no such
exciting discoveries have been made for glioma therapy in the past 25 years (1).
Glioblastomas are infamous because of their aggressive nature and resistance to
conventional cytotoxic injuries, such as radiation and chemotherapy (2). Survival
data on glioma patients reveals that after chemotherapy, radiation, and surgical
resection, the patient only has a life expectancy of fourteen months, and most
succumb to their illness within two years (1). In fact, due to the high rates of
mortality, malignant gliomas are the first leading cause of cancer death in
children, the third leading cause of cancer-related death among men 15-54 and
the fourth for women 15-34 years of age. Gliomas are resistant to apoptosis; thus
new modes of cell death must be explored.

Autophagy
Autophagy is a basal process that is essential to normal function of life.
Autophagy is a cellular process the cell undergoes in response to stresses, such
as starvation and pathogen infection (reviewed by (3)). The cell digests proteins
and organelles to provide energy for homeostatic function and catabolic
processes (reviewed by (3)). The cell has internal sensors for monitoring energy
and nutrient levels and, in turn, regulates protein translation and autophagy in
response to any changes.
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Autophagy is a crucial process in order to function properly. Defective
autophagy has been demonstrated to have detrimental effects for multiple
species, such as Saccharomyces cerevisiae (4) Dictyostelium discoideum (5),
Drosophila melanogaster (6, 7), and Caenorhabditis elegans (8) .

Two

autophagy genes have been extensively studied for their role in embryogenesis,
Atg5 and Becn1. Mice null for an essential gene, Atg5, die within 12 hours of
birth, if starved, versus around 21 hours for the wild-type mice (9). However,
homozygous deletion of Beclin 1 causes mice to die at embryonic day 7.5 (10).
There are two main biochemical markers that scientists can use to monitor
autophagy in higher eukaryotes: LC3, and p62 (11, 12). ATG5 has been shown
to be an indicator of autophagy during adenovirus infection (13). ATG5 almost
exclusively exists in a covalently bound complex to ATG12 (14). ATG12 is
bound to ATG5 through the actions of the ubiquitin E1 and E2-like ligases, ATG7
and ATG10, respectively (14, 15). ATG5/12 then associates with ATG16 in an
800kDa complex and localizes to the phagophore (16). The localization of the
complex is required for the recruitment of LC3 to the phagophore.
LC3 is the most common protein used to monitor autophagy. LC3 exists
primarily in two forms: LC3-I and LC3-II. The LC3-I, and is cleaved by ATG4 to
the

mature

form

LC3-II.

LC3-II

is

subsequently

lipidated

to

a

phosphotidylethanoamine by an E2-like enzyme Atg7 and incorporated into the
phagophore (17). Scientists can monitor the cleavage of LC3-I to LC3-II through
western blotting or by analyzing cellular localization of fluorescent tagged LC3
(11). p62, along with LC-3, binds poly-ubiquinated proteins and directs them to
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the autophagosome to be degraded (18, 19). p62 is then subsequently degraded
by the autophagolysosome.

Autophagy during the viral life cycle
Autophagy during virus infection has largely been associated with viral
clearance and major histocompatibility complex type II antigen presentation (20).
Recently, the viral-associated autophagy field has diverged to also explore how
viruses have hijacked this evolutionarily conserved process in order to aid in
replication. (+) RNA viruses, which replicate in the cytoplasm, manipulate
intracellular membrane structures to form replication complexes (reviewed by
(21)).

Dengue virus, equine arteritis virus, and mouse hepatitis virus all

colocalize at sites of DNA replication with double-membrane vesicles in the
cytoplasm ((22-24) reviewed by (21)). LC3 was shown to colocalize with virusinduced vesicles leading researchers to agree that these were, in fact,
autophagosomes (23, 24). Mouse hepatitis virus yields fall by a factor of 1000 in
the absence of ATG5 (23). On the other hand, human cytomegalovirus, HIV
Type I and herpes simplex virus must thwart autophagy in order to have a
productive viral life cycle (20, 25, 26).

Five labs, including ours, have

demonstrated that adenovirus is associated with autophagy (13, 27-31). We
propose that in contrast to the RNA viruses, adenovirus is a DNA virus that
replicates in the nucleus; therefore it should not utilize cytoplasmic located
autophagosomes for replication scaffolds; furthermore suggesting that the
adenovirus-induced autophagy serves a distinct justification and constitutes a
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separate regulatory mechanism. Since autophagy is associated with adenoviral
replication, we believe that autophagy is beneficial for adenovirus and must serve
some purpose. Our theory suggests that adenovirus replication leads to
excessive consumption of ATP and amino acids, generating a potential deficit of
energy resulting in the triggering of autophagy to generate materials for
adenovirus replication. Autophagy has been speculated as a mechanism to
provide the cell with ATP during stressful times (32).

Adenovirus
Adenovirus is a common virus that most humans develop immunity to by
the time they reach adolescence. Adenovirus causes acute upper respiratory
infections and conjunctivitis (33-35). There are 51 different human adenovirus
serotypes (36-38). The studies here are based upon Class C Adenovirus type 5,
a non-oncogenic adenovirus. Adenovirus is an encapsidated, double-stranded
DNA virus (38). Adenovirus encodes 34 proteins from both strands of DNA. The
genome holds three transcription groups: early transcription genes, delayed
transcription genes, and late transcription (38). Replication is broken down into
three stages. The first 2-4 hours of after infection is deemed the immediate-early
infection. This is when E1 (E1A, E1B55K, and E1B19K) is expressed. From
hours 4-12 is early infection. E2, E3, and E4 are expressed. After 12 hours is
considered late infection. The transcription and translation is focused on capsid
proteins.
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The Delta-24-RGD voyage from bench to bedside
Delta-24 has a 24-nucleotide deletion that renders it unable to bind to E1A
(39). This virus cannot replicate in cells with a competent Rb pathway, which
makes it cancer specific. Second generation Delta-24, Delta-24-RGD, has a
RGD-4C sequence inserted in the HI loop of the fiber knob (40). Glioma cells are
known to have increased amounts of RGD-binding integrins on their surface, an
observation exploited by Delta-24-RGD, whose RGD domain increases its
binding efficiency to gliomas. Delta-24-RGD has been a successful anticancer
therapy in osteosarcoma, lung, prostate, cervical, and ovarian cancer cell lines
(31, 41-44). Delta-24-RGD has recently been administered to patients in Phase I
clinical trials in M. D. Anderson Cancer Center, and furthermore, it is being tested
in the University of Alabama-Birmingham for ovarian cancer (45). Previous
studies focused on the ability of Delta-24-RGD to kill cancer cells (13, 28, 29),
and this study is unique because it will focus on mechanistic studies underlying
Delta-24-RGD and wild-type adenovirus-mediated autophagy by manipulating
and enhancing cell death to increase the antiglioma effect.

Potential Interactions of Adenoviral Early Genes in the Role of Autophagy
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Figure 1: Proposed interactions of adenovirus early proteins and their potential
interaction with proteins/pathways involved in autophagy.
Adenovirus has many potential genes that may be responsible for
inducing autophagy (figure 1).

Primarily, adenoviral proteins are expressed

either as early genes or late genes. Early gene E1A binds to the retinoblastoma
protein and is necessary for the virus to replicate (46). Loss of E1 renders the
virus unable to replicate. Early gene E1B19K is a Bcl-2 homolog responsible for
the inhibition of apoptosis (47).

We hypothesize that E1B19K disrupts the

balance of Bcl-2 binding to Beclin 1, thus favoring autophagy.

Early gene

E1B55K binds to p53 to inhibit apoptosis and p53 is a known upstream regulator
6

of DRAM (48) (49). E3 is associated with cell death (50, 51). E4 is necessary for
host cell shutoff, late gene expression, and DNA replication (52). E4 is also
associated with mTOR activation (53). It has been shown that E4-ORF-1 and
E4-ORF-4 from adenovirus are able to mimic the growth factor signals by
activating PI3-kinase, thus activation of mTOR (53).

mTOR is an important

regulator of cell growth. It serves as the cells’ sensor for nutrient and growth
factor signals (53). Adenoviral VA RNA binds to and blocks the activation PKR
(54) which is also a regulator of autophagy (55). Our goal is to elucidate the
mechanism in which adenovirus triggers autophagy in the host cell.

Bioenergy Sensing pathways and Autophagy
“Whole-body energy metabolism” is an extremely delicate process with
multiple checks and balances (Steinberg, G., et al., 2009).

The body uses

different cytokine signals to communicate energy needs in each tissue. On a
cellular level, AMP-activated protein kinase (AMPK) has been identified as the
translator of these extracellular signals (reviewed by (56)). AMPK is charged
with regulating metabolism based on energy demand and supply within the cell.
In times of nutrient deficiency, AMPK inhibits growth primarily by exerting
inhibition over the master growth regulating kinase mTOR (57).

AMPK is

involved in other equally valuable functions of the cell, such as regulating
polarity, cell structure, and fatty-acid production (reviewed by (58)).
LKB1 regulation of AMPK
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On the road to discovering the genetic principle behind the familial disease,
Peutz-Jeghers syndrome, researchers in Finland found the gene LKB1 to be
inactively mutated in most patients (59).

This was the first description of a

cancer-susceptibility syndrome caused by inactivation of a protein kinase (59).
LKB1 is classically known as the sensor of metabolic energy and maintaining
homeostasis in the cell by activating AMPK (60), but it is also responsible for
positively regulating 13 other proteins in the AMPK-related family of kinases also
essential in regulating cellular polarity and structure (61). LKB1 distinguishes
between these responsibilities by delegating AMPKα and SIK in regulating
energy homeostasis and eliciting MARK proteins, SAD proteins, and AMPKα2 to
regulate cell polarity and structure. LKB1 activates the downstream kinases via
direct phosphorylation in their activation loops (reviewed by (58)).

LKB1

activates AMPK by phosphorylation of Threonine 172 (Thr172).

AMPK

propagates the signal through phosphorylation of downstream substrates
(reviewed by (62)).

AMPK
AMPK is a heterotrimeric protein consisting of a catalytic α domain and
regulatory β and γ subunits (63).

AMPK binds to AMP and ATP in the

cystathionine-β-synthase domain of the γ domain. The α and γ subunits are
tethered together via the β subunit (63). Upon binding AMP, AMPK undergoes a
conformational change allowing phosphorylation of Thr172 by an upstream
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kinase; however, binding ATP does not produce a conformational change,
subsequently inhibiting upstream kinase-mediated phosphorylation (64).
Of many responsibilities, AMPK specifically regulates autophagy, cell
growth, and protein translation through inhibition of mTOR. Specifically, AMPK
inhibits mTOR by phosphorylation of the upstream inhibitor of mTOR, TSC1/2.
AMPK can also directly inhibit mTOR by phosphorylating raptor, a subunit of the
mTORC1 complex (reviewed by Hezel (58)). A more robust description of mTOR
regulation is discussed below.

TSC1/2
TSC1 and TSC2 were identified as tumor suppressors in the 90s after
isolating the genetic loci frequently mutated in the autosomal dominant syndrome
TSC that causes multiple benign tumors (65). TSC1/2 exists in a heterodimeric
complex essential to prevent ubiquitin-mediated degradation.

While, TSC2

contains the enzymatic GAP activity, TSC1 is required to stabilize TSC2. The
TSC1/2 complex often has mutations in the GAP domain of TSC2 or mutations in
TSC1 that lead to destabilization, and both of which are regularly causes of the
TSC disease (reviewed by (65)). TSC1/2 are activated by numerous pathways,
including the PI3K-AKT, ERK-RSK, and LKB1-AMPK pathways. After activation
through LKB1, AMPK propagates its signal though TSC1/2 via phosphorylation of
TSC2 on Serine 1387 and Threonine 1271, subsequently stimulating TSC2 GAP
activity (66). The complex mode of action during the phosphorylation of TSC2 is
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not entirely known, however, it is known that TSC2 mediates its effects through
negatively regulating the GAP activity of Rheb (reviewed by (65)). When the
GAP activity of TSC2 is stimulated, it converts the GTP-bound form of Rheb to
the GDP-bound form, however Akt activation is opposite. Akt phosphorylates
TSC2 at a different site from AMPK phosphorylation to inhibit the GAP activity of
Rheb, therefore stimulating mTOR activity.

mammalian Target of Rapamycin
mTOR is a 240kDa protein that can exist in two complexes: mTORC1 and
mTORC2. mTORC1 consists of mTOR, raptor, mLST8, PRAS40 while mTORC2
consists of mTOR, rictor, mLST8, and SIN1 (67, 68). mTORC2, is primarily
associated with actin organization and feedback inhibition of Akt and is not
relevant, with respect to AMPK regulation.

mTORC1 is responsible for the

regulation of protein translation in response to growth factors and nutrient
availability, and autophagy as well.

In order for mTORC1 to have maximal

catalytic activity it must be associated with GTP-bound Rheb. Rheb is only in the
GTP-bound state when TSC2 GAP activity is suppressed, such as Akt activation.
When Rheb binds to mTOR, mTORC1 positively regulates the phosphorylation of
two effectors, S6K (p70S6 kinase) and 4E-BP1 (eukaryotic initiation factor 4E
binding protein 1), which allow protein translation under favorable conditions (67).
On the other hand, mTOR is also responsible for the phosphorylation of ULK-1
and Atg13 to promote autophagy (69). Under normal growth conditions, mTOR
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is activated though the PI3K/Akt pathway resulting in cell growth. However,
when nutrients are withdrawn, or AMPK is stimulated, mTOR is inhibited through
activation of TSC1/2 which inhibits Rheb binding to mTOR eventually halting
protein synthesis and inducing autophagy.

eIF2α pathway in Autophagy
eIF2α is a translation factor that is responsible for halting translation in
response to cellular stresses. There are four kinases that regulate eIF2α (figure
2). PERK (70), GCN2 (71, 72), HRI (73), and PKR (74)(reviewed in (75)). eIF2a
can selectively translate certain mRNAs based on which stressor it is responding
to (reviewed in (76)). Our focuses were mainly on GCN2 and PERK as HRI is
mainly a tissue specific protein, primarily erythroid-specific and PKR is
inactivated by adenovirus (77, 78).

Figure 2: Upstream kinases that regulate eIF2α activity.
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PERK
PERK is activated upon ER stress, such as the unfolded protein response
(70). PERK then phosphorylates eIF2α to reduce global protein synthesis (79).
However, during ER stress there is preferential translation of mRNA, such as
ATF4 (80-83).

ATF4 is known to be upregulated by the unfolded protein

response, oxidative stress and amino acid starvation (79). Continued ER stress
can lead to the induction of autophagy (84, 85).

Induction of autophagy is

thought to help clear the unfold protein aggregates and aid in cell survival (85).

GCN2
GCN2 is an evolutionarily conserved kinase that was first identified in
yeast (86).

GCN2 is primarily a surveyor of intracellular amino acids and has

been shown to be required for proper amino acid starvation adaptation in in vivo
mouse models (72, 87). GCN2 has a domain that binds to uncharged tRNAs that
functions as a sensor for available amino acids (88, 89). When there is an
abundance of uncharged tRNAs, GCN2 is activated and phosphorylates eIF2α to
halt translation (88, 90). However, GCN2 can regulate protein translation in
response to UV irradiation, as well (71). GCN2 has been indicated in autophagy
induction during amino acid starvation via an eIF2α dependent mechanism (55).
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Chapter 2: Material and Methods

Cell culture
MRC-5 human fibroblasts, U251-MG, U87-MG, and HeLa cells were
cultured in Dulbecco’s modified Eagle medium/F12 medium
supplemented

with

10%

fetal

bovine

serum

(1:1, v/v)
and

1%

penicillin/streptomycin/amphotericin B (Invitrogen, Carlsbad, CA). AMPKα1-/-α2-/mouse embryonic fibroblasts (MEFs) (Keith Laderoute, SRI),
GCN2-/- and WT MEFs (Douglas Cavener, PSU), PERK-/- and WT MEFs (David
Ron, PSU) were cultured in Dulbecco’s modified Eagle medium (1:1, v/v)
supplemented

with

10%

fetal

bovine

serum

and

1%

penicillin/streptomycin/amphotericin B. All cells were grown in a humidified
atmosphere containing 5% CO2 at 37°C.
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Viruses and Virus Propagation
Table 1.

Gene Mutation

Virus Name

Source

E1-Deleted

AdOLE/1.8

MDACC

Original Source

Adenoviral Core
E3-Deleted

Ad300

E1A Mutation

Delta-24

Juan Fueyo

Athanassios

P.

Kyritsis (39)
Fiber

Delta-24-RGD

Ramon Alemany

Alemany

(42)

Modification
E1B55K-Deleted

Ramon

dl1520/Onyx-O15

Ramon Alemany

Frank McCormick
(91)

E1B19K-Deleted

Delta-E1B19K

Our Laboratory

Our Laboratory

E4-Deleted

dl366

Clodagh O’shea

Tom Shenk (92)

Delta-VA RNA

Ad-VAdel

Ramon Alemany

Ramon
(93)
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Alemany

Acidic Vesicular Organelles Analysis with Flow Cytometry

2x105 cells were seeded in a 6 well plate.

The same day cells were

treated as indicated and incubated for 48-72 hours. Acridine Orange (SigmaAldrich, St Louis, MO) was added to the cells for a final concentration of 1µg/ml
and incubated for 15 minutes in the cell culture incubator.

The media was

collected and spun at 14,000 RPM for 20 seconds the supernatant was
aspirated. Remaining cells were washed once with PBS, trypsinized, collected in
PBS, and spun in the same tube as before. Cells were resuspended in 200-500µl
of PBS. Samples were analyzed on a Becton Dickson Flow Cytometer with
CellQuest software.

Transfection
U-87 MG cells were transiently transfected using FuGENE6 with either
pCDNA3.1 empty vector or pCDNA3.1-12s E1A cDNA expressing vector (gift
from Dr. Mein Chie Hung, MD Anderson Cancer Center, Houston, TX) per the
vendors instructions. Cells were collected 48-96 hours after transfection and
subjected to immunoblotting.
U-87 MG cells were stably transfected using FuGENE6 with an eGFP-LC3
expressing plasmid (Noburu Mizushima, Japan). The cells were selected with
G418 at a concentration of 700µg/ml. After selection the cells were plated at a
concentration of 4x104 cells per well in Lab Tek II chamber slides (Cole-Parmer,
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Vernon Hills, Illinois). Cells were infected as indicated and after 48 hours the
media was aspirated and the cells were fixed in 4% paraformaldehyde for 30
minutes at -20°C. The cells were washed with PBS and mounted with ProLong
Gold Antifade reagent with Dapi (Invitrogen, Carlsbad, CA). Images of the cells
were taken and processed on a Zeiss Axiovert Zoom fluorescence microscope
(Carl Zeiss, Inc., Thornwood, NY, USA) equipped with AxioCam MRM camera
and 40x 1.3 oil EC Plan-NEOFLUAR objective, using Immersol (n = 1.518) at
room temperature. Acquisition software was AxioVision Release 4.7.1 (Carl
Zeiss, Inc.).
Immunoblotting
Cells (1x106 in a 10cm dish) were treated as indicated.

Samples

containing 40µg of protein were subjected to 1.5 mm 12% or 6% SDS-Trisglycine gel electrophoresis.
Carlsbad, CA).

We also used 4-20% Novex gels (Invitrogen,

Proteins were transferred to Whatmann nitrocellulose

membranes or PVDF membranes (Bio-Rad, Hercules, CA ) using a Bio-Rad
Semi-Dry transfer machine at 25V for 30 minutes or 20V for 1 hour for larger
proteins. Membranes were blocked in 10% Non-fat dry milk solubilized in 1x
TBS-0.05% Tween-20. Membranes were incubated overnight in 2% Nonfat dry
milk in 1x TBS-0.05% Tween-20 with antibody. Membranes were washed three
times (15min, 5 min, 5 min) with 1x TBS-0.05% Tween-20. Antibody complexes
were detected using chemiluminescence reagent (GE Amersham, Piscataway,
NJ ) in accordance with the manufacturer's instructions.
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Table 2.
Antibody

Dilution

Company

Atg5

1:2000

Cosmo Bio, Japan

LC3

1:1000

Cell Signaling, Danvers, MA

p62 (WB)

1:200

Santa Cruz Biotechnology, Santa Cruz, CA

eIF2α

1:1000

Cell Signaling, Danvers, MA

Phospho-eIF2α

1:1000

Cell Signaling, Danvers, MA

Actin

1:4000

Santa Cruz Biotechnology, Santa Cruz, CA

GCN2

1:1000

Cell Signaling, Danvers, MA

Phospho-GCN2

1:1000

Cell Signaling, Danvers, MA

E1A

1:200

Santa Cruz Biotechnology, Santa Cruz, CA

P62 (IF)

1:600

Sigma Aldrich, St. Louis, MO

Electron Microscopy
Cells were seeded in a ten centimeter dish (1-2x106) and infected at 100
MOI. If indicated, cells were treated with Bafilomycin A1, a vacuolar ATPase
inhibitor, (Sigma Aldrich, St. Louis, MO) at a concentration of 10nM. Cells were
collected and pelleted at 300 x g were rinsed with PBS and fixed in a solution
containing 3% glutaraldehyde plus 2% paraformaldehyde 1% Millipore-filtered
uranly acetate.

Samples were dehydrated in increasing concentrations of

ethanol, infiltrated, and embedded in LX-112 medium.

Samples were

polymerized in a 70˚C oven for two days. Ultra thin sections were cut in a Leica
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Ultracut microtome (Leica, Deerfield, IL), stained with uranyl acetate and lead
citrate in a Leica EM Stainer, and examined in a JEM 1010 transmission electron
microscope (JOEL, USA, Inc., Peabody, MA) at an accelerating voltage of 80kV.
Digital images were obtained using AMT Imaging System (Advanced Microscopy
Techniques Corp, Danvers, MA).

Crystal Violet Staining
8.0x104 cells were seeded in a 24 well plate and infected with adenovirus
as indicated. 96 hours later the media was aspirated, cells were washed with
PBS, and stained with 0.05% Crystal Violet (Sigma, St Louis, MA) in 20%
methanol for 10 minutes. Cells were washed and crystal violet was solubilized
with 1% SDS and read at a wavelength of 570nm.

Quantitative Real Time-PCR
Cells (1x106 per well in 10cm plates) were infected with wild type
adenovirus type 5, with a MOI of 100. Twenty hours after infection, cells were
collected and mRNA was extracted using the RNeasy kit (Qiagen, Valencia, CA).
Samples were subjected to the turbo DNA free kit to remove all traces of DNA
(Ambion, Austin, TX) and sent to for the autophagy PCR array (SA Biosciences,
Frederick, MD).
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Antibody Kinase Array
MRC5 cells were either mock infected or infected at a MOI of 100 and
collected at 16, 32, or 48 hours post infection. Lysates were subjected to the
human phospho-kinase array kit that was purchased from R&D Systems
(Minneapolis, MN) and used according to the manufactures instructions.

siRNA and shRNA technologies
The pLKO.1 vector was a generous gift from Robert Weinberg, Whitehead
Institute, Boston, MA. 7x105 HEK-293T cells were plated in 5ml of a 6cm culture
dish. 24 hours later pLKO.1, psPAX2, and pMD2.G were cotransfected with
FuGENE6 (Roche Diagnostics, Indianapolis, IN) for 15 hours. 48 hours later the
media was collected and stored a 4°C and fresh media was added to the
remaining cells. 24 hours later the media was collected again and combined with
the previous media collected.
to pellet cell debris.

The media was spun at 1,250 rpm for 5 minutes

The media-containing virus was stored at -80°C.

The

supernatant was used to infect 0.5x106 U251-MG cells. 8µg/ml of polybrene was
added to the cells and 1ml of supernatant was added to the cells. 24 hours after
infection 1µg/ml of puromycin was added for selection of infected cells.
To knockdown ATG5, we purchased a shRNA-expressing plasmid from
Origene (Rockville, MD, USA). We transfected the plasmids into the U87 cells
with FuGENE 6. The cells were screened, and stable cell clones were
maintained in culture medium plus 0.5 µg/ml puromycin.
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Replication assays
Cells were seeded at 4x104 in a 12 well plate and infected at 100 MOI for
24 hours. The supernatant or cell extract was boiled at 95°C for 10 minutes and
used as the DNA template.

Platinum SybR Green (Invitrogen, Carlsbad, CA)

was used as per manufactures instructions. PCR was performed on a Bio-Rad
iCycler with parameters: Cycle 1-95°C 5 mins, Cycle 2-30- 95°C 30s, 60°C 20s,
and 70°C 20s. Cycle thresholds were compared to known quantities of the
adenoviral genome in order to derive the genome copy number.

Infectious Viral Particles
Viral titer was assessed using the Adeno-X-Rapid Titer kit (BD
Biosciences, Palo Alto, CA). Cells were subjected to three freeze thaw cycles to
release the virus. The diluted virus was seeded over 1x105 293 cells in 24 well
plates. The cells were fixed with methanol at -20°C for two minutes 48 hours later
after infection. Cells were incubated at 37°C for two hours with goat anti-hexon in
PBS containing 1% bovine serum albumin. Cells were washed 3 times with
PBS+1% bovine serum albumin. Cells were incubated with goat conjugated
HRP antibody (Vector Laboratories, Burlingame, CA) for two hours. Cells were
washed 3 times with PBS+ 1% BSA.

HRP substrate was added per

manufactures instructions (Vector Laboratories, Burlingame, CA). Samples were
developed using DAB tablets (Sigma-Aldrich, St. Louis, MO). Positive cells were
be visualized on a compound light microscope. Mathematical equations are used
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to derive the titer were calculated using the equation from the Adeno-X-Rapid
Titer kit (BD Biosciences, Palo Alto, CA). Briefly we calculated the number of
fields in the objective, multiplied by the number of hexon positive cells, divided by
the dilution factor, and multiplied by the volume of virus.

Quantification of cell lysis
The cells were stained with 8 µM ethidium homodimer 1 (Molecular
Probes, Inc., Eugene, OR) in phosphate-buffered saline solution (PBS) for 15
minutes at room temperature. Stained cells were then analyzed by flow cytometry
using a FACScan cytometer and CellQuest software (Becton Dickinson). Red
(FL2-H channel) fluorescence emissions from 104 cells were analyzed.

Plaque Forming Assays
Cells were plated overnight at varying densities in a 6-well plate. The next
day the cells were infected at the indicated PFU for 1 hour. The media was
removed and the cells were washed. 10% SeaPaque agarose was mixed and
melting with ddH2O. The agarose was diluted with culture media. Once the
agarose had cooled to around 40°C it was added to the cells. After the agarose
cooled 1 ml of culture media was added to the cells. Between days 5 and 7 the
cells were stained with MTT and the diameter and quantity of the plaques was
determined using the UN-SCAN-IT gel version 6.1 software (Silk Scientists,
Orem, UT).
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Animal Experiments
All animals were purchased through Jackson Laboratory and housed in
the MD Anderson BSRB Animal Facility. The GCN2 knockout mice (B6.129S6Eif2ak4tm1.2Dron/J), originally generated by Dr. David Ron and were back
crossed with C57BL/6J mice. C57BL/6J mice served as the wild-type strain.
The animals were injected with Ad300, measured in virus particles/mouse, via tail
vein injection. Their weight was measured pre-injection and post-mortem. The
mice were monitored every day for moribundity. If the mice appeared moribund
then they were sacrificed and all of their organs were preserved. The tissues
were processed and embedded through the MD Anderson Department of
Veterinary Medicine.
Immunofluorescence
The organs were deparaffinized by baking the slides for 1 hour at 65°C.
They were subsequently incubated in 3 washes of Xylene, 2 washes of 100%
Ethanol, 2 washes in 95% Ethanol, and 1 wash in 70% Ethanol for 3 minutes
each. Then they were washed 3 times in PBS+ 0.05% Tween-20, and diH20 all
for 5 minutes each. The slides were then heated in prewarmed 10mM Sodium
Citrate pH 6.0 for 30 minutes in a steamer. The slides were allowed to cool for
20 minutes on the bench top. Slides were then washed three times in PBS+
0.05% Tween-20 for 5 minutes. The sections were marked using a hydrophobic
pen and incubated overnight with the antibody and an IgG control with the same
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amount of IgG from the 1° antibodies species. The next day the slides were
washed 3 times with PBS+ 0.05% Tween-20 and incubated with the 2° antibody
at a 1:400 dilution and incubated for 1 hour. The slides were washed 3 times
with PBS+ 0.05% Tween 20 for 5 minutes each. The slides were counterstained
with VECTASHIELD mounting medium with Dapi (Vector Laboratories,
Burlingame, CA). Images of the tissues were taken and processed on a Zeiss
Axiovert Zoom fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY, USA)
equipped with AxioCam MRM camera and 40x 1.3 oil EC Plan-NEOFLUAR
objective, using Immersol (n = 1.518) at room temperature. Acquisition software
was AxioVision Release 4.7.1 (Carl Zeiss, Inc.).

Immunohistochemistry
The organs were deparaffinized by baking the slides for 1 hour at 65°C.
They were subsequently incubated in 3 washes of Xylene, 2 washes of 100%
Ethanol, 2 washes in 95% Ethanol, and 1 wash in 70% Ethanol for 3 minutes
each. Then they were washed 3 times in PBS+ 0.05% Tween-20, and diH20 all
for 5 minutes each. The slides were then heated in prewarmed 100mM Sodium
Citrate pH 6.0 for 30 minutes in a steamer. The slides were allowed to cool for
30 minutes on the bench top. Slides were then washed three times in PBS+
0.05% Tween-20. The sections were marked using a hydrophobic pen and
incubated overnight with the antibody and an IgG control with the same amount
of IgG from the 1° antibodies species. The next day the slides were washed 3
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times with PBS+ 0.05% Tween-20 and incubated with the 2° antibody at a 1:400
dilution and incubated for 1 hour. 30 minutes before use the ABC reagent was
prepared (Vector Laboratories). The slides were washed 3 times with PBS+
0.05% Tween 20. The slides were incubated with the ABC reagent for one hour.
Slides were washed 3 times with PBS+ 0.05% Tween-20. DAB+ H2O2 (Sigma
Aldrich, St. Louis, MO) tablets were dissolved in tap water and added to the
sections. Once the slides were developed, they were washed 3 times in 3 with
PBS+ 0.05% Tween-20. Slides were dipped in Hematoxylin for 30 seconds and
rinsed in water for five minutes. Slides were incubated in 95% Ethanol, Xylene 3
times each for 3 minutes and mounted with Permamount (Sigma Aldrich, St
Louis, MO). Pictures were obtained through an Olympus BX41 with Olympus
DP71 camera.
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Chapter 3: Results
Significance and Rationale
Autophagy was discovered approximately forty years ago as a cellular
response to starvation. It has only recently been examined enough to join the
ranks of apoptosis as an established form of programmed cell death. In the past
decade, many labs have focused on the relationship between viruses and
autophagy. Autophagy investigation has become increasingly popular in
laboratories studying pathogen infection and immunity (reviewed by (94)), but
scientists have also examined how viruses manipulate the autophagy pathway to
their advantage (reviewed by (95)). Our collaborator was the first to report that
conditionally replicating adenoviruses induce autophagy (29), and, unfortunately,
no group until ours has pursued any mechanistic studies. Therefore, it is
imperative for the advancement of the area of adenovirus and autophagy that
this is explored more in depth because understanding how adenovirus mediates
autophagy is crucial translationally as a potential anticancer therapy, because of
the many cancers that are highly resistant to conventional pro-apoptotic
therapies.
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3.0 Examination of the Role Infection and Early Genes Play in Adenovirus
Mediated Autophagy
The role of replication during autophagy was carried out through
experiments with adenovirus deleted of the E1 gene, rendering it incapable of
replication.

U87.GFP-LC3 cells were generated by Dr. Hong Jiang at the

University of Texas MD Anderson Cancer Center (MDACC).

The GFP-LC3

plasmid was originally constructed by Dr. Noboru Mizushima (96).

U87.GFP-

LC3 cells have a low basal level of autophagy, thus providing an optimum cell
line for autophagic studies. Autophagy is identified by punctate GFP staining of
the cells versus diffuse cytoplasmic staining in the absence of autophagy. The
technique follows the movement of LC3-I to LC3-II incorporation into the
autophagosome. U87.GFP-LC3 cells were infected with the AdOLE/1.8 virus
(Delta-E1) purchased from the Keck Memorial Adenovirus Core at MDACC
(figure 3). At increasing MOI, there was no increase in the GFP-LC3 punctate
formation. Uninfected cells were used as a negative control and serum and
glucose starved cells were the assay’s positive controls. Delta-24-RGD infected
cells served as a control for comparison between viruses. There was a 2.5 fold
increase in GFP-LC3 punctuation in Delta-24-RGD infected cells over Delta-E1
infected cells. These results provide evidence that infection does not play a role
in adenovirus-mediated autophagy.
A second technique to confirm the role of infection on autophagy induction
was to assay autophagy is through the accumulation of an acidotropic dye within
the autophagosome. Acridine orange emits red fluorescence when localized in
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an acidic compartment and fluoresces green when bound to DNA. After infection
with Delta-E1, there was no significant increase in the acidic apartments of the
cell (figure 4). Mock infection and serum and glucose starvation were used as
assay positive controls. Ad300 infection served as an infection control. There
was almost a 14-fold increase in acidic vacuoles in Ad300 infected cells over
Delta-E1 infected cells. Looking at the scattered population of cells, one sees
that under glucose and serum free media starvation the population of cells
increase in intracellular complexity.

This can be contributed to the vacuolar

structures now present in the cytoplasm. Now examining wild-type infected cells
the population increases in intracellular complexity but also in DNA content due
to virus replication. Acridine orange when bound to DNA fluoresces green and
this is monitored through FL1-H. During infection with a Delta-E1 virus there was
no population shift in either direction, suggestion no increase in vacuoles or viral
replication. Infection does not increase acidic compartments in the cell.
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Figure 3: A Replication-Deficient Virus Failed
to Induce GFP-LC3 Punctata. A) U87-MG
were stably transfected with a GFP-LC3
construct.

Cells

were

visualized

by

fluorescence microscopy and cells with more
than 5 GFP-LC3 punctata were considered
positive for autophagy. Cells were incubated in
complete media for 48 hours and infected with
dl309 (an E1-deleted virus) at the multiplicity
of infection (MOI) indicated.

Incubation in

serum and glucose media served as a positive control. B) GFP-LC3 positive
cells were quantified. Around 200 cells were counted per well and three wells
were counted.
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Figure 4: A Replication-Deficient Virus Did Not Increase Lysosomal Vacuoles. A)
Cells were treated as indicated. 48 hours after infected cells were incubated for
15 minutes with Acridine Orange (1µg/ml). Cells were trypsinized and collected in
PBS and analyzed by a Becton Dickson flow Cytometer. B) Quantification of
acridine orange flow cytometry.
Ultrastructure morphology analysis is the gold standard for autophagy
identification, therefore to confirm the previous experiments we infected MRC-5
fibroblasts with Delta-E1 or wild-type adenovirus and compared the morphology
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to the uninfected control (figure 5).

Cells that were uninfected displayed a

continuous cytoplasm sprinkled with mitochondria. The morphology for a cell
infected with Delta-E1 looked remarkably similar. There was no disruption in the
cytoplasm.

However, cells infected with wild-type adenovirus displayed a

strikingly different morphology. The cytoplasm was littered with vacuoles that
appeared empty but upon amplification there are remnants of digested material
inside of the vacuoles. In the enlarged inset there are multi-lamellar structures
inside of a vacuole to be digested. The nucleus has multiple virions present.
Since there was no change in morphology we can interpret that infection does
not play a role in autophagy induction.
For biochemical confirmation, we analyzed the proteins p62 and LC3 for
changes indicative to autophagy induction. p62 is a long-lived protein that is
preferentially digested by autophagy (18). Western blot analysis of the quantity
of p62 within the cell is an indicator of autophagy.

In accordance with our

hypothesis, after infection with Delta-E1 there was no degradation of p62, and
there was a decrease after infection with Delta-24-RGD (figure 6). A second
biochemical marker of autophagy is the cleavage and subsequent lipidation of
MAP-LC3b (LC3).

Under basal conditions LC3 is primarily found in the

uncleaved state, LC3-I.

Monitoring this cleavage from LC3-I to LC3-II is

indicative of autophagy. Mock and Delta-E1 cells had a similar ratio of LC3II/LC3-I.

However, upon infection with Delta-24-RGD all of the LC3-I was

converted to LC3-II. Therefore, with all of these results we can conclude that
infection is not sufficient to induce autophagy.
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Figure 5: Electron Micrographs Revealed No Ultrastructural Morphological
Changes After Infection with Delta-E1. MRC-5 fetal lung fibroblasts were treated
for 72 hours and then fixed and processed for electron microscopy. A) Mock
Infected Cells, 6000x magnification. B) Delta-E1 infected at 100 MOI, 6000x
magnification. C) Ad300 infected at 100 MOI, 6000x magnification. D) Ad300
infected at 100 MOI, 25000x magnification. Dotted arrow: late stage
autolysosome. Solid arrow: autophagosome

Figure 6: Only Replication Competent Viruses Induced Cleavage of LC3-I and
Degradation of p62. MRC-5 fibroblasts were infected at 100 MOI for 72 hours.
Cell were collected and subjected to western blotting. A) p62 levels decreased
after infection with a replication competent virus (Delta-24-RGD) and fail to
decrease with the replication deficient virus. LC3 was cleaved after infection with
Delta-24-RGD and not after infected with Delta-E1. B) Densitometry of LC3-I
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Figure 7: Exogenous Expression of E1A Did Not Result in the Induction of
Autophagy. A) U87-MG cells were transfected with pCDNA3.1+ or pCDNA3.1E1A 12S vectors for 48, 72, or 96 hours and analyzed for autophagy. B)
Densitometry of the cleavage of LC3-I to LC3-II.

34

3.1 Overexpression of E1A Fails to Induce Autophagy
We next asked whether E1A, the gene responsible for the replication
deficiency in the Delta-E1 virus, was sufficient to induce autophagy when
expressed alone. Using a pCDNA3.1-12s E1A expression vector, U87 cells were
transiently transfected and subsequently analyzed for autophagy via western
blotting (figure 7). Comparing each time point to its own empty vector control
there was no difference in the level of p62 despite strong E1A expression.
Examination of LC3 in these same samples revealed no difference in the ratio of
LC3-II/LC3-I. We can conclude that E1A is required for adenovirus-mediated
autophagy, but not sufficient.

3.2 Examining the Role of Adenoviral Early Genes on Autophagy Induction
In order to isolate the function adenoviral early genes play in autophagy
induction, we utilized viruses deleted for each early gene separately. We were
able to obtain knockout viruses for E1, E3, E1B55K, E4, and VARNA I&II. We
constructed the E1B19K deleted virus though the generation of stop codons in
the open reading frame using site-directed mutagenesis (figure 8, top). The
mutated sequence was confirmed through sequencing (figure 8, bottom).
Secondly, we analyzed the virus for expression of E1B19K and E1B55K (figure
9). We chose to amplify the mutant virus that had similar levels of E1B55K
expression compared to wild type, while lacking expression of E1B19K. Or first
goal was to examine the capability of Delta-E1B19K to induce autophagy. Our
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first comparative studies with Delta-E1B19K, were acridine orange staining after
infection with Ad300 or Delta-E1B19K. We showed that there were similar levels
of AVO positive cells in a dose dependent manner (figure 10).

These results

indicate that E1B19K plays a partial role in adenovirus-mediated autophagy.

Figure 8: Schematic Representing the Generation of an E1B19K Mutant
Adenovirus.
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Figure 9: Mutant Virus Failed to Express E1B19K, with No Effect on E1B55K. A)
293 serves as a positive control for E1B55K and E1B19K. U251-MG cells were
mock infected, AdCMV (Delta-E1) infected, Ad300 (WT) infected, and E1B19K
KO infected.

Figure 10: Delta-E1B19K Increased the Volume of Acidic Compartments After
Virus Infection.

A) U251-MG cells were infected at the MOI indicated and

analyzed for acridine orange staining 48 hours post infection.
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Acridine orange examination of Delta-E1B19K revealed there was not a
complete abolishment of autophagy. We chose to examine this phenomenon
more in depth. E1B19K is known to interact with E1B19K interacting Protein
(Bnip3) through a BH-like domain. Bcl-2 encompasses a BH3 domain that binds
to Beclin 1 to inhibit autophagy.

E1B19K is a homologue of BCL-2.

We

proposed that E1B19K interacted with Beclin 1 to regulate autophagy. The first
experiment was immunoprecipitation of E1B19K and examination of Beclin 1.
Infection of HeLa cells with Delta-24-RGD or Delta-E1B19K and subsequent coimmunoprecipitation revealed that only an E1B19K expressing adenovirus could
co-immunoprecipitate Beclin 1 (figure 11).

The converse experiment pulling

down Beclin 1 could still precipitate E1B19K.

Therefore, we concluded that

E1B19K does, in fact, bind to Beclin 1 in vitro.
It is relevant to also establish the Beclin 1 binds to PI3K CIII. Beclin 1
must associate with PI3K CIII in order to induce autophagy. A time course
experiment revealed that PI3KCIII associated in a complex with E1B19K and
Beclin 1 while BCL2 did not (figure 12). Beginning at 6 hours post infection
PI3KCIII was detected with co-immunoprecipitation with Beclin 1 while BCL2
detection in the complex decreased. Simultaneously, immunoprecipitation with
E1B19K revealed that PI3KCIII co-immunoprecipitated with increased time while
BCL2 was never detected. We discovered that E1B19K competes with Bcl-2 to
bind Beclin 1 and that Beclin 1, E1B19K, and E1B19K all exist in a complex
together.
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We noticed through gross microscopic analysis of the cells revealed that
at 48 hours 100% of the cells were floating and revealing cytopathic effect. We
chose to look at the induction of apoptosis because earlier studies revealed there
was not an increase in autophagy induction.

Infection with Delta-E1B19K

revealed an increase in cleaved PARP while only in the presence of E1B19K
PARP remained in the uncleaved form (figure 13).

Therefore, deletion of

E1B19K fails to induce autophagy, which subsequently leads the cells to undergo
apoptosis.
Since there was an increase in apoptosis, we sought to establish whether
the replication cycles of these to virus were similar. HeLa cells were infected
with Ad300, Delta-E1B19K and Delta-24-RGD (figure 14). 48 hours later the
cells and supernatant were collected and analyzed for infectious viral progeny.
Delta-E1B19K had a 70% and 64% decrease in replication compared with Ad300
(student’s t-test p=0.0004) and Delta-24-RGD respectively. Deletion of E1B19K
causes the cells to undergo apoptosis causing the cells to die before a full
replication cycle has concluded.
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Figure 11: E1B19K Binds to Beclin 1 in vivo. Infection with of HeLa cells with
Delta-24-RGD or Delta-E1B19K and subsequent co-immunoprecipitation reveals
that only an E1B19K expressing adenovirus can co-immunoprecipitate Beclin 1.
The converse experiment pulling down Beclin 1 can still precipitate E1B19K.
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Figure 12: A Time Course Experiment Revealed that PI3KCIII Associates in a
Complex with E1B19K and Beclin 1 while BCL2 Does Not. Beginning at 6 hours
post infection

PI3KCIII was detected with immunoprecipitation with Beclin 1

while

detection

BCL2

in

the

complex

decreased.

Simultaneously,

immunoprecipitation with E1B19K revealed that PI3KCIII co-immunoprecipitated
with increased time while BCL2 was never detected.
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Figure 13: Infection With Delta-E1B19K Led to Increased Cleavage of PARP.
Cells were infected with each virus and assayed by Immunoblotting for PARP
cleavage.

Figure 14: Delta-24-RGD Revealed Impaired Replication.

HeLa cells were

infected with Ad300, Delta-E1B19K and Delta-24-RGD. 48 hours later the cells
and supernatant were collected and analyzed for infectious viral progeny.
p=0.0004.
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We examined the ability of all of our knockout viruses to induce
autophagy. Ultrastructure morphology studies revealed similar results as earlier
stated. The Delta-E1 infected control cell displayed a continuous cytoplasm with
mitochondria and ER clearly present.

The cell infected with Delta-24-RGD

adenovirus has a disrupted cytoplasm with autophagic vacuoles. Item D shows a
phagosome with multi-lamellar structure present and also vacuoles with digested
material inside. The nucleus was spotted with virions. Infection with Delta-E3,
Delta-E1B19K, Delta-E4, and Delta-VARNA all exhibited a similar phenotype
(figure 15:A-L). None of the genes were required for adenovirus mediated
autophagy.
It was also important that we examined LC3 punctuation after infection
with the mutants for biochemical confirmation. Cells with more than five GFPLC3 dots were considered positive for autophagy.

Replication competent

mutants had a 3-7 fold increase in the number of autophagy positive cells over
the mock treated and Delta-E1treated controls (figure 16).

This experiment

indicated that no single viral gene tested, except E1A, is required for adenovirusmediated autophagy.
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Delta-E1 Infected cell
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Delta-24-RGD Infected cell
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Delta-E3 Infected cell
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Delta-E1B19K Infected cell

47

Delta-E4 Infected cell

48

Delta-VA RNA I Infected cell
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Figure 15: Ultrastructure Studies of MRC-5 Infected with Adenovirus Mutants
Revealed the Presence of Autophagosomes. A) Delta-E1 virus 100 MOI, 5000x
magnification. B) Delta-E1 virus 100 MOI, 25000x, magnification. C) Delta-E3
virus (Delta-24-DGD) 100 MOI, 6000x magnification. D) Delta-E3 virus (Delta24-DGD) 100 MOI, 25000x, magnification. E) Delta-E3 virus (Ad300) 100 MOI,
6000x magnification. F) Delta-E3 virus (Ad300) 100 MOI, 25000x, magnification.
G) Delta-E1B19K virus 100 MOI, 6000x magnification. H) Delta-E1B19K virus
100 MOI, 25000x, magnification. I) Delta-E4 virus (dl366) 100 MOI, 6000x
magnification. J) Delta-E4 virus (dl366) 100 MOI, 25000x, magnification. K)
Delta-VARNA virus 100 MOI, 6000x magnification. L) Delta-VARNA virus 100
MOI, 25000x, magnification.

Dotted arrow: late stage autolysosome.

arrow: autophagosome
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Solid

Figure 16: All Mutant Viruses, Induced GFP-LC3 Punctate Staining.

U87-MG

cells stably transfected with GFP-LC3 and either mock infected or infected with
adenovirus mutants at 30 MOI. Cells with greater than five GFP-LC3 punctata
were considered positive for autophagy. A) 1.Mock infection. 2. Delta-E1. 3.
Delta-24-RGD. 4. Delta-E3. 5. Delta-E1B55K. 6. Delta-E1B19K. 7. Delta-E4. 8.
Delta-VARNA-I. B) Quantitation of the wells.
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4.0 Intracellular ATP levels decrease after adenovirus infection
Jiang et. al. 2008 proposed that a possible mechanism of adenovirusmediated autophagy was that the virus induces a hyperanabolic state. Increased
energy demands for the production of the virus can stress the cell and deplete
ATP stores. We wanted to measure the intracellular levels of ATP after virus
infection and we were able to accomplish this by utilizing an Intracellular
bioluminescence kit that needs ATP to facilitate the reaction of D-luciferin and O2
to produce light. We infected U251 cells at 100 MOI for 24-72 hours (figure 17).
We collected the cells by lysing them in water and used an aliquot as the ATP
source for our bioluminescent reaction.

At 24 hours there was a 2.6 fold

decrease in ATP levels. That difference increased to 4 and 5 fold at 48 and 72
hours respectively. Therefore, there is a decrease in ATP which could be a
trigger for autophagy induction.
4.1 Intracellular sensors for ATP as effectors of autophagy induction
LKB1 is the kinase that regulates AMPK.

AMPK is the sensor for

intracellular ATP. In order to study the role that LKB1 and AMPK play in the
induction of adenovirus mediated autophagy we obtained shLKB1 U251 cells and
AMPKα1α2 null MEFs from our collaborators. U251 cells were transfected with
shRNA against LKB1 and clones were picked to analyze the expression level.
We chose the clone with the least amount of expression and infected the
parental, shControl, and shLKB1 cell lines with 30 MOI of Ad300 (figure 18).
Infection of shLKB1 had no bearing on the ability of adenovirus to induce

52

autophagy. We analyzed acidic vacuoles and LC-3 cleavage and there was no
difference between the parental cell lines, control cells lines

or the

knockout/knockdown cell lines. Infection with AMPKα1α2 null MEFs revealed
similar findings (figure 19 and 20). This data indicate that LKB1, and AMPK do
not play a role in adenovirus-mediated autophagy.

Figure 17:

Infection with Ad300 Decreased the Levels of Intracellular ATP.

U251 cells were plated in triplicate and infected with Ad300 at 100 MOI. Every
24 hours the cells were collected, lysed in diH2O and analyzed using an ATP
intracellular bioluminescence assay. ANOVA p< 0.0001.
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Figure 18: shLKB1 Knockdown Cells Revealed No Difference in Acridine Orange
Staining Compared to Wild-type Cells. A) U251-MG, shCont and shLKB1 cells
were infected at 30 MOI and analyzed for acridine orange staining 48 hours post
infection.

Figure 19: AMPKα1α2 Null MEFs Revealed No Difference in Acridine Orange
Staining Compared to Wild-type Cells.

Underwent Autophagy After Virus

Infection. A) AMPK wild-type and AMPKα1α2 null MEFs were infected at 50 MOI
and analyzed for acridine orange staining 48 hours post infection.
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Figure 20: AMPKα1α2 Knockout Cells
Underwent Autophagy After Virus Infection. A) AMPK wild-type and AMPKα1α2
knockout cells were infected at 50 MOI and analyzed for LC3 cleavage 48 hours
post infection. B) Densitometric analysis of LC-3 cleavage.

4.2 Adenovirus activates the AKT pathway during late stage viral infection
The current model of starvation-mediated autophagy implies a decrease in
the activity level of the AKT/mTOR pathway. Using an antibody array, we found
that AKT was phosphorylated in response to adenovirus infection at residue
S473 16 hours after infection and at residue T308 36 hours after infection (Figure
21). AKT must be phosphorylated at both residues to be maximally active (97).
This indicates that it was only active during the late stage of viral infection, 36
hours. Interestingly levels of phosphorylation on residue S2448 of mTOR were,
in most part, unchanged until the late stage of viral infection. Interestingly, one of
the most prevalent mTOR targets, p70S6K, was phosphorylated at its active site,
T398 despite little or no changes of mTOR phosphorylation at 16 hours.
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AKT

and mTOR are activated during late hours of infection and therefore we looked
further into the pathway.
4.3 Downregulation of TSC2 fails to prevent adenovirus-mediated
autophagy.
To further dissect the role of the AKT/AMPK/mTOR pathway, we obtained
TSC2 knockdown cells to examine the role TSC2 played in the induction of
autophagy after adenovirus infection. U251 cells were transfected with shRNA
against TSC2 and clones were picked to analyze the expression level. We
chose the clone with the least amount of expression and infected the parental,
shControl, and shTSC2 cell lines with 30 MOI of Ad300 (figure 22). There was
no change in the volume of acidic compartments or the number of cells that were
positive for acidic compartments.

We also analyzed LC-3 cleavage as an

indicator of autophagy and found there was no difference between any of the cell
lines (figure 23). TSC2 does not play a role in adenovirus mediated autophagy
therefore, there with the array data and the lack of involvement of TSC2, we
cannot conclude that the AKT/mTOR pathway play a role in adenovirus-mediated
autophagy.
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Figure 21: Activation of the AKT Pathway After Adenovirus Infection. A) MRC-5
cells were infected at 100 MOI and collect at 16, 32, and 48 hours. The lysates
were subjected to an AKT antibody array from R&D Systems.

Figure 22: shTSC2 Knockout Cells Revealed No Difference in Acridine Orange
Staining Compared to Wild-type. A) Generation of TSC2 shRNA downregulated
cell line. B) U251 parental, shCont, or shTSC2 cells were infected at 30 MOI and
analyzed for acridine orange staining 48 hours post infection.
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Figure 23: shTSC2 Cells Undergo Autophagy After Virus Infection. A) TSC2
wild-type and TSC2 downregulated cells were infected at 30 MOI and analyzed
for LC3 cleavage 48 hours post infection.

4.4 eIF2α Phosphorylation Increases After Viral Infection
Other pathways besides the AKT pathway are known to induce
autophagy. For instance, PKR is known to phosphorylate eIF2α during viral
infections (55).

Thus, we monitored eIF2α phosphorylation levels during

adenoviral infection, in our study. MRC-5 cells were infected at 100 MOI, and
eIF2α phosphorylation was monitored every 12 hours. Figure 24 demonstrates
that eIF2α phosphorylation increased starting 36 hours after infection and
culminated with a 3-fold total increase at 48 hours, with no change in the total
levels of eIF2α. There was also an inverse correlation with the levels of eIF2α
phosphorylation and the decrease in the levels of p62, suggesting that eIF2α
may be involved in autophagy induction.
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4.5 Examination of PERK
There are four kinases that are responsible for eIF2α phosphorylation. Of
those four, we chose to examine PERK and GCN2. PERK activation is primarily
monitored by investigating its downstream effectors. PERK increases translation
of chaperone proteins during ER stress. We infected U251 cells at 100MOI and
examined disulfide isomerase (PDI) and BiP (figure 25). Unexpectedly, we saw
a disappearance of these proteins after virus infection despite an increase in
eIF2α phosphorylation.
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Figure 24: Translation Initiation Factor eIF2α is Phosphorylated During
Adenovirus Infection. U251-MG cells were infected at 100 MOI and the cell
lysates were analyzed by

western

blotting for autophagy and eIF2α

phosphorylation status. A) eIF2α is phosphorylated between 24 and 48 hours
after virus infection without changes in the total levels of eIF2α. This degradation
also correlates with a dramatic p62 degradation. B) Densitometry of phosphoeIF2α/total eIF2α and normalized to actin. C) Densitometry of p62 normalized to
actin.

Figure 25: ER Stress Proteins are Degraded During Virus Infection. A) U251
Cells were infected and cell lysates were collected at the time points indicated.
PDI and BiP (chaperone proteins) were degraded after virus infection despite
eIF2α phosphorylation.
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4.6 Examination of GCN2
Next, we obtained GCN2 knockout mouse embryonic fibroblasts to study
the role of GCN2 in the induction of autophagy. Upon infection it was abundantly
clear that these cells were highly resistant to the cytopathic effect of the virus
(figure 26).

Trypan blue viability studies confirmed the observation.

Mock

treated cells were 94% and 96% viable for wild-type and knockout cell lines,
respectively (figure 27). Similar levels of viability were seen with Delta-E1
infected cells with 91 and 94% viability, respectively. However, at 50 MOI and
100 MOI viability dropped 64% and 70% for wild-type cells, respectively. The
GCN2 knockout cells had relatively no change in viability 50 and 100 MOI yielded
90 and 92% viability, respectively ( student’s t-test p=0.0001). A second method
was used to examine viability of the cells, crystal violet. Cells were seeded in a
12-well plate and infected at increasing MOI (figure 28). 96 hours later cells were
stained with the dye crystal violet. Most of the wild-type cells were completely
cytopathic and lifted off of the plate at 50 MOI. This supports the lack of change
in the trypan blue viability data at 50 and 100 MOI for wild-type cells. However,
the amount of crystal violet retained by GCN2 knockout cells remains fairly
constant, with only a slight decrease in crystal violet retention at 160 MOI. We
repeated the experiment with an MOI up to 300 and we still continued to see a
resistance of GCN2 knockout cells to adenovirus induced cytopathic effect (figure
29). We concluded that GCN2 was involved in the cellular response to the virus
and decided to examine autophagy induction.
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In order to examine autophagy in the GCN2 null cells, we used acridine
orange, an acidotropic dye, to quantify the acidic vacuoles in the cell. The cells
were infected at 50 MOI and analyzed with acridine orange 72 hours later (figure
30). There was a 3-fold increase in the percent cells positive for acidic vacuoles
over the GCN2 null cells. This data implies that the GCN2 cells are impaired for
autophagy induction after adenovirus infection.
For further conformation on the presence of autophagy we analyzed the
cells for LC3 cleavage. Both cell lines were infected at 50 MOI and analyzed 48
hours post infection (figure 31). LC3-I was completely cleaved into LC3-II and
that autophagosome completely degraded LC3-II, where it was not visible via
western blotting. On the other hand, there was only slight cleavage of LC3-I to
LC3-II in the GCN2 knockout cells. GCN2 cells do not undergo autophagy.
To confirm our biochemical data we analyzed the cells for autophagy
through the gold standard for visualization of autophagy, which is electron
microscopy. Both cell lines were infected with the same multiplicity of infection
and fixed 72 hours post infection. Wild-type cells displayed a similar morphology
to human cells infected with virus (figure 32b). The only difference was the lack
of virions present in the cell due to the semi-permissive replication status of
murine cells. This was expected as these cells are only semi-permissive to
adenovirus replication. However, the GCN2 knockout cells appeared extremely
similar to the untreated control cells (32a and d). There was no rounding of the
cell and no gross vacuolar structures in the cytoplasm. We concluded GCN2 null
cells do not undergo autophagy like their wild-type counterparts.
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Figure 26: GCN2 Null Mefs are Resistant to Virus Infection. A) Wild-type and
knockout MEFS were seeded at 5x105 cells per well. Cells were infected at 50
MOI and visualized by phase contrast microscopy 72 hours post infection.
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Figure 27: GCN2 Knockout MEFs Have Increased Viability After Adenovirus
Infection. 4x104 cells were seeded in a 12-well plate infected at the indicated
MOIs. Floating cells were collected and the remaining cells were rinsed with
PBS, trypsinized and combined with the floating cells and analyzed on an
automated cell counter.
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Figure 28: Loss of GCN2 Renders Cells Resistant to Adenovirus Infection.
8.0x104 cells were seeded in a 24 well plate and infected with adenovirus as
indicated. 96 hours later the media was aspirated, cells were washed with PBS,
and stained with 0.05% Crystal Violet in 20% methanol for 10 minutes. Cells
were washed and crystal violet was solubilized with 1% SDS and read at a
wavelength of 570nm in a spectrophotometer. Two way ANOVA, p<0.0001.
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Figure 29: Even at High Mulitiplicities of Infection, GCN2 KO Cells are Resistant
to Virus Infection. 8.0x104 cells were seeded in a 24 well plate and infected with
adenovirus as indicated. 96 hours later the media was aspirated, cells were
washed with PBS, and stained with 0.05% Crystal Violet in 20% methanol for 10
minutes. Cells were washed and crystal violet was solubilized with 1% SDS and
read at a wavelength of 570nm in a spectrophotometer.
p<0.0001.
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Two way ANOVA,

Figure 30: GCN2 Knockout MEFs Have Decreased Levels of Autophagy After
Infection. A) 2x105 cells were seeded per well in a six-well plate and treated as
indicated. Cells were analyzed 48 hours post infection. Students t-test, p<0.001

Figure 31: GCN2 Null MEFs Failed to Cleave LC3 or Degrade p62 After Virus
Infection. 1x106 GCN2 Wild-type and GCN2 Knockout MEFs were seeded in a
10cm dish and infected at 50 MOI. Cells were harvested 72 hours post infection
and subjected to immunoblotting.
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Figure 32: Ultrastructure Analysis Revealed a Lack of Autophagosome Induction
After Virus Infection in GCN2 Knockout MEFs. A) GCN2 Wild-type MEFs, mock
infected, 4000x Magnification. B) GCN2 Wild-type MEFs, Ad300 infected, 4000x
Magnification. C) GCN2 Knockout MEFs, mock infected, 4000x Magnification.
D) GCN2 Knockout MEFs, Ad300 infected, 4000x Magnification. Solid arrow:
autolysosome.

4.7 In vivo analysis of GCN2
It was important to not only understand the implications of GCN2
deficiency in vitro but we also wanted to analyze the role of GCN2 in vivo. We
infected wild-type and GCN2 knockout mice with adenovirus and analyzed the
difference in liver morphology and cytotoxicity. Adenovirus has a strong tropism
for the liver and therefore is the most appropriate organ to examine for
adenovirus toxicity. We found that the knockout mice had a strikingly different
morphology compared to wild-type mice.

The knockout mice had twice the

amount of necrosis compared to wild-type mice. At high doses of viral infection
which kill the mice in 3 days, wild-type pathology revealed acute coagulation
periportal necrosis (figure 33A). However, in the knockout mice the necrosis was
not confined solely to the periportal region anymore (figure 33B). The necrosis
was diffused throughout the liver. The knockout mice also had hemorrhage in
their liver.

At three days there was no evidence of infiltration and the Kupffer

cells were still inactive. This was probably due to the insufficient time for the
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immune system to react.

We were, however, able to detect E1A via

immunohistochemistry in both of these livers (figure 34A and B). Therefore we
can conclude that the E1A was responsible for the cell death in these livers.
Mice that were infected with 5x109 vp/mouse and euthanized on day 7 revealed a
less severe pathology. Both groups had necrosis and the knockout mice had
twice the amount of necrosis versus the wild-type group (figure 35 a) (student’s ttest p<0.05).

An interesting finding was that E1A expression seemed to be

congruent with cell death (figure 35b). The knockout mouse livers had twice the
amount of cell death and half the amount of E1A. At day 7, one can visualize the
increased lymphocytic infiltration and Kupffer cell hyperplasia, although there
was increased Kupffer cell hyperplasia in the knockout mice. Interestingly the
knockout mice also had depletion of their bone marrow as revealed by
microscopic analysis of their femur and sternum. In order to characterize
autophagy in these animals we performed immunofluorescence for the
autophagy protein p62 (figure 36).

p62 punctuation in the cytoplasm was

revealed in wild-type mice infected with adenovirus while the GCN2 knockout
mice infected with virus did not have p62 foci in the cytoplasm; nor did the PBS
controls. Therefore, we can conclude that the GCN2 null mouse livers in vivo do
not undergo autophagy, similarly to the GCN2 null cells in vitro.
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A

B

Figure 33: GCN2 Null Mice Undergo Large Amounts of Necrosis and
Hemorrhage After Infection with Extremely High Viral Doses. GCN2 wild-type (A)
and knockout mice (B) were injected with 1x1011 vp/mouse via tail vein injection.
The mice were euthanized 3 days later. Solid arrow: necrosis. Dashed arrow:
hemorrhage.
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A

B

Figure 34: GCN2 Wild-type and Null Mice Both Express E1A. GCN2 wild-type
(A) and knockout mice (B) were injected with 1x1011 vp/mouse via tail vein
injection. The mice were euthanized 3 days later. Their livers were extracted,
embedded in paraffin, and subjected to E1A immunohistochemistry.
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Figure 35: Cell Death in Mouse Livers is Congruent with E1A Expression. Mice
were infected with 5x109 virus particles per mouse and analyzed for E1A and cell
death.
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Figure 36: Autophagic Analysis of Livers from GCN2 Wild-type and Knockout
Mice. Mice were infected with 5x109 virus particles per mouse or PBS via tail
vein injection. Mice were euthanized and their livers were fixed in formalin and
analyzed for the autophagy protein p62.

5.0 Examination of Cell Lysis after Adenovirus Infection
To first examine the correlation between adenovirus replication and
autophagy we treated cells with the late stage autophagy inhibitor Bafilomycin A1
(figure 37). The control cells had a continuous cytoplasm with no disturbances.
Treatment with Bafilomycin alone did halt the basal autophagy process and
vacuoles with undigested material were detected. Treatment with adenovirus
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was visually drastically different than with Bafilomycin alone.

Most of the

vacuoles appeared white or empty and some had some remnants of digested
cytoplasmic material.

However, treatment with Bafilomycin and adenovirus

revealed a substantial increase in the number of vacuoles suggesting a decrease
in the turnover of vacuoles. The vacuoles were filled with undigested material.
Treatment with Bafilomycin A1 did not increase cell lysis and viral particles were
visible in the nucleus (figure 37). We wanted to analyze whether the inhibition of
autophagy had any effect on replication and we confirmed that replication was
still occurring though a replication assay (figure 38). There was no statistical
significant difference between untreated and Bafilomycin treated cells.
We believed that lysis may be a late event in viral replication. Therefore,
we decided to visualize the process of lysis during adenovirus infected through
time point experiments chronicling every 12 hours of virus infection from 0 hours
to 120 hours (figure 39). We infected U251 cells with 100 MOI of wild-type
adenovirus. Figure 39 shows 0 hours, 72 hours, 96 hours, and 108 hours. At 72
hours the membranes remained intact. There was a large quantity of virus in the
nucleus and large vacuoles in the cytoplasm. However, there was still strong
staining by osmium tetroxide. It was not until 96 hours when it was possible to
see active breakage of the membrane. The cytoplasm was being degraded as
evidenced by lack of osmium tetroxide staining. At 108 hours the nucleus and
cytoplasm were completely degraded. The cells had no membrane integrity.
The inset shows where the outer membrane was broken and released contents
into the media.

We can derive from this experiment that autophagy does
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participate in degradation of the cytoplasm and membrane the can aid in cell
lysis.
5.1 Autophagy induces and inhibitors regulate the viral plaque area
One assay to asses viral spread and lysis is through a plaque forming
assay. The media is replaced by agarose so the virions cannot passively move
and infect the neighboring cells. We first examined, the autophagy inducer,
rapamycin on its ability to increase viral lysis. We showed that there was a dose
dependent increase in the total area of plaques (figure 40). From virus alone to
virus plus 300nM of rapamycin there was a 1.88 fold increase in the area of
plaques. 300nM to 500nM increase in rapamycin concentration increased the
area of plaques by 1.38 folds. Therefore comparing 500nM rapamycin to virus
alone there was an increase of 2.6 folds. We saw a slight increase in the number
of plaques and wanted to further examine the effect on replication with hexon
staining assays. U251 cells were infected at 30 MOI with wild-type adenovirus
and the cells and supernatant were collected and examined for the presence of
infectious virions (figure 41).

There was a significant increase in the titer

between virus alone and virus plus rapamycin (p=0.0052).

Therefore, we

conclude that rapamycin does aid in viral lysis and increases replication.
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Figure 37: Bafilomycin Inhibits Autophagosomal Degradation During Adenovirus
Infection. MRC5 cells were either mock infected (A), treated 150µM Bafilomycin
A1 (B), infected at 100 MOI with Ad300 (C), or treated with 150µM Bafilomycin
A1 and infected with Ad300 (D). Solid arrow: autophagosome. Dashed arrow:
autolysosome.

Figure 38: Treatment with Bafilomycin A1 Does Not Have an Effect on Viral
Replication. MRC5 cells were treated with DMSO or Bafilomcyin A1 at 150µM.
They were infected at 100 MOI with Ad300. After 72 hours the supernatant and
the cells were collected and subjected two 3 freeze thaw cycles. The virus
containing media was used for a hexon staining replication assay.
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Figure 39: U251 Cells Infected with Ad300 Display Increased Membrane
Degradation Over Time.

1x106 U251 cells were plated in a 10cm dish and

infected with 100 MOI. Cells were collected at the time point indicated and
analyzed for cell lysis A) 0 hours B) 72 hours C) Inset of 72 hours. Long arrow
indicates viral inclusion. White arrow shows double membrane. Small arrow
indicated virus particle. D) 96 hours E) 108 Hours. Long arrow indicates
membrane breakage. F) Inset of 108 hours. Small arrow indicates virus particle.
Long arrow indicates membrane breakage.
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Figure 40: Rapamycin Increased the Number of Plaques and the Size. Cells
were plated, infected as indicated, overlaid with agarose, and treated with
Rapamycin as indicated. 7 days later the cells were stained with MTT and lysis
was quantified.
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Figure 41: Rapamycin Increased Viral Titer. U251 cells were treated with DMSO
or Rapamycin at 300nM. They were infected at 100 MOI with Ad300. After 96
hours the supernatant and the cells were collected and subjected two 3 freeze
thaw cycles.

The virus containing media was used for a hexon staining

replication assay. p=0.0052
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We also wanted to further study the phenomenon of increased viral lysis
with autophagy inducers and thus we chose 2-deoxyglucose (98).

2-

deoxyglucose is a glucose analog that cannot be broken down and halts
glycolysis (99). Treatment of U2-OS cells with virus alone at 200 and 400 PFU
did not increase the total area of pixels (figure 41). There was a 2.9 fold increase
in the total pixel area with 800 PFU. Looking at the same PFU but with treatment
and without treatment with 2-DG showed a 1.28, 5.78, and 3.18 fold increase for
200, 400 and 800 PFU, respectively. The autophagy inducer 2-DG, similar to
rapamycin, increases cell lysis.
Conversely, experiments with an autophagy inhibitor, 3-MA were
undertaken to examine the effect of autophagy impairment on cell lysis. Cells
were treated with 1mM and 3mM 3-MA and infected at 150 PFU (figure 42).
There was a decrease in the total number of plaques after 3-MA treatment and
there was also 3-fold decrease in the total read of plaques, however not in a
dose dependent manner.

Therefore, we can conclude that inhibition of

autophagy with 3-MA decreases viral spread.
5.2 3-MA decreases cell lysis
As a more direct assay for examining lysis, we used a dye, ethidium
homodimer-1 that only stains dead (permeable) cells. We used 3-MA to inhibit
autophagy during virus infection. As proof of principle, we stained the cells with
acridine orange and there was a significant decrease in AVO positive cells after
treatment with 3-MA (student’s t-test p=0.001) and there was a significant
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increase in AVO positive cells after virus treatment with water as a control
(student’s t-test p=0.005) (figure 44a). To examine the lysed cells we sorted the
cells along with x-axis with forward scatter and along with y-axis with log FL-3.
Treatment with the virus and water as a control led to a 25% increase in lysed
cells (student’s t-test p=0.001), while treatment with virus and 3-MA leads to less
than a 15% increase in lysed cells (student’s t-test p=0.003) (figure 44b).

Figure 42: 2-Deoxyglucose Increased the Number of Plaques and the Size of
Plaques. Cells were plated, infected as indicated, overlaid with agarose, and
treated with 2-DG as indicated. 7 days later the cells were stained with MTT and
lysis was quantified.
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Figure 43: 3-Methyladenine Decreased Plaque Number and Overall Plaque Size.
Cells were plated, infected as indicated, overlaid with agarose, and treated with
3-MA as indicated. 7 days later the cells were stained with MTT and lysis was
quantified.
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Figure 44. 3-MA Inhibits AVO formation and Cell Lysis. U-87 cells were treated
with 3-MA and adenovirus an analyzed for AVO formation and cell lysis using
ethidium homodimer 1.
5.3 Knockdown or downmodulation of ATG5 impairs cell lysis
We also used a cell biology approach to inhibit autophagy versus using
chemical inhibition. Atg5 knockout mouse embryonic fibroblasts were a gift from
Dr. Seiji Kondo (100). In order to understand the role autophagy plays during
lysis we utilized autophagy-deficient ATG5 knockout MEFs to study lysis during
viral infection. The first experiment was to study the morphological changes after
virus infection.

Electron microscopy revealed a complete difference in

morphology between the wild-type and knockout cell lines (figure 45).

The

morphology was similar to the GCN2 deficient cells after infection with
adenovirus.

There was no rounding of the cells, no accumulation of

autophagosomes or degradation of the cytoplasm in knockout cells compared to
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wild-type cells. Cytoplasmic whorls were present in the wild-type infected cell
line. We concluded that Atg5 null cells do not display a phenotype corresponding
to autophagy after adenovirus infection. We decided to study this further using
lysis assays.
Infection of wild type and ATG5 deficient cells led to a drastically different
phenotype. Infection with the virus in autophagy deficient cells does not cause
cytopathic effect. In a dose dependent experiment infection with 20, 50 and 100
MOI leads to a complete conversion of LC3-I to LC3-II at 100 MOI and no
conversion at all in the ATG5 knockout MEFs (figure 46). Interestingly there is
differential expression in fiber between the two cell lines.

Fiber starts to

accumulate at 20 MOI and it does not start to appear in the wild-type cells until
50 MOI. Wild-type mouse cells undergo autophagy and cells deficient for ATG5
do not undergo autophagy.
Next we examined the difference between cell lysis in these to cell lines.
Application of ethidium homodimer-1 to the cells revealed a 3.5% cell death with
mock, and 10.2, 37.9 and 69.8 for 20, 50 and 100 MOI respectively (figure 47).
While in the ATG5 deficient cell lines the amount of cell lysis was 1.9, 2.6, 5.0
and 9.1 for mock, 20, 50, and 100 MOI respectively. While there was a slight
increase in the number of lysed cells there was still a 7.7 fold increase in the
number of lysed cells after 100 MOI between the two cell lines. This experiment
showed that autophagy is important for cell lysis.
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When we analyzed replication we found there was no difference between
Bafilomycin A1 treated cells and vehicle treated cells. We opted to downregulate
the autophagy protein ATG5 to inhibit autophagy (figure 48).

We stably

transfected U87 cells with shRNA against ATG5 and selected the two clones with
the largest decrease of ATG5 and least functional autophagy pathway. Western
blot analysis confirmed the decrease in ATG5 expression and we used 2 clones,
#2 and #11 for our experiments. Upon infection of the cells with 10 MOI Delta24-RGD for 72 hours there was complete conversion of LC3-I to LC3-II in the
parental and shControl cell line (figure 47). However, in the shATG5 2 and 11
cell lines there was no conversion despite the presence of the viral protein fiber.
Therefore, similar to the mouse cell lines, ATG5 does play a role in adenovirusmediated autophagy and deletion or knocking down ATG5 impairs autophagy
induction.
We subsequently analyzed lysis in these cell lines. Further analysis with
acridine orange revealed there was a 30% decrease in AVO positive cells
between shControl and shATG5 11 (student’s t-test p=0.0005) (figure 52).
Application of ethidium homodimer-1 revealed a 60.9±4.2% decrease in the
number of lysed shATG511 cells compared to the shControl cell line (student’s ttest p=0.00326) (figure 51). There 21.6±1.1% and 25.7±1.7% dead cells in the
parental and shControl infected cells compared to 2.6±0.0% and 3.3±0.4% under
mock conditions (student’s t-test p=0.001, p=0.0027 respectively). Deletion of
ATG5 plays a significant role in AVO formation and cell lysis.
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We performed a burst cell assay on these clones to identify whether lack
of replication was important to cell lysis (figure 50). Parental, shControl, and two
shATG5 cell lines were infected at 100 MOI for one hour, the media was
replaced and the supernatant was analyzed for E1A transcripts 24 hours later by
quantitative-real time PCR.

There was no statistical difference between the

control and knockdown cell lines. We also analyzed production of infectious viral
progeny. The two control and two knockdown cell lines were infected at 10 MOI
and the cell lysates and supernatant were collected 72 hours post infection and
analyzed for viral particle quantitation.

There was no statistical difference

between the control and knockdown cell lines, indicating replication was not
compromised in these cells.
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Figure 45: Infection of ATG5 Knockout MEFs Did Not Induce Autophagic Vacuole
Formation. Atg5 wild-type and Atg5 knockout MEFs were infected at 100 MOI for
72 hours. There were fixed and subjected to processing for electron microscopy.
Arrows indicate autophagosomes.

Figure 46: Infection of ATG5 Knockout MEFs Did Not Induce LC3 Cleavage.
ATG5 wild-type and ATG5 knockout cells were infected as indicated and after 72
hours the cells were subjected to Immunoblotting for virus and autophagy
proteins.
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Figure 47: Membrane Degradation was Decreased in ATG5 Null Cells Compared
to Wild-type. Atg5 wild-type and Atg5 knockout mouse embryonic fibroblasts
were infected as indicated for 72 hours and incubated with 8µM Ethidium
Homodimer 1 for 15 minutes and analyzed by flow cytometry for cell membrane
permeability

Figure 48: Generation of an ATG5 Downregulated Cell Line. U87 cells were
transfected with an shATG5 plasmid.
ATG5 expression.
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Clones were chosen and assayed for

Figure 49: Cells with Downregulated ATG5 Failed to Cleave LC-3 After
Adenovirus Infection. Cells were infected at 10 MOI for 72 hours and the protein
was collected and assayed for LC-3 cleavage and the adenoviral structural
protein fiber.

Figure 50: Downregulation of ATG5 Led to Decreased Acidic Compartment
Volume. Cells were seeded in a 6-well plate and infected with Delta-24-RGD for
48 hours. Cells were analyzed by flow cytometry after acridine orange staining.
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Figure 51: Downregulation of ATG5 Decreased Cell Lysis.

U87 Parental,

shControl and shATG5 cells were infected at 10 MOI for 72 hours and incubated
with 8µM Ethidium Homodimer 1 for 15 minutes and analyzed by flow cytometry
for cell membrane permeability.
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Figure 52: Downregulation of ATG5 Did Not Affect Viral Replication. The U87
parental, control, and shATG5 cells were infected with Delta-24-RGD at 100 MOI
for 24 hours. A) The media was collected and used at a template for E1A PCR
to determine the number of E1A copies. B) The supernatant and the cells were
collected and subjected two 3 freeze thaw cycles. The virus containing media
was used for a hexon staining replication assay.
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Chapter 4
Conclusions
1) Infection with a replication-deficient virus failed to induce autophagosomes

formation.

2) Replication deficient viruses, as opposed to replication competent, failed

to induce cleavage of LC3 I to LC3 II and degradation of p62.

3) Cells infected with a replication competent adenovirus induced GFP-LC3

punctuation.

4) Cells infected with a replication competent adenovirus increased the acidic

compartment of the cell, correlating with autophagy.

5) Transient, exogenous expression of E1A did not increase LC3 conversion

or increase p62 degradation.

6) Electron Micrograph studies revealed E1B55K, E1B19K, E3, E4, and

VARNA mutant adenoviruses induce autophagy.

7) E1B55K, E1B19K, E3, E4, and VARNA mutant adenoviruses induced

GFP-LC3 punctuation, thus correlating with autophagy.
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8) AKT was activated during virus infection.

9) Loss of AMPK had no effect on adenovirus-mediated autophagy.

10) eIF2α phosphorylation correlated with p62 degradation after virus

infection.

11) Adenovirus did not upregulate ER-stress proteins.

12) Loss of GCN2 rendered the cell resistant to adenovirus infection.

13) Loss of GCN2 correlated with resistance to autophagy after adenovirus

infection.

14) In vivo infected wild-type mice underwent autophagy in the liver while

GCN2 knockout mice failed to undergo autophagy.
15) Livers of GCN2 knockout mice displayed twice as much necrosis and cell

death compared to wild-type mice.

16) Infection with adenoviruses increased the number of autophagic vacuoles

and Bafilomycin decreasesd the turnover over autophagic vacuoles
without impairing replication.

17) Lysis of the cell after adenoviral infection was a late process.
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18) The use of autophagy inducers increased the size of viral plaques, while

the autophagy inhibitor 3-MA reduced the size of plaques.

19) ATG5 null MEFs and shATG5 cells failed to undergo autophagy and have

decreased cell lysis.

During this study we found that replication is not sufficient to induce
autophagy and that only viruses that replicate can induce autophagy. We
found that, of the early genes tested, there was not one single gene that
was responsible for the induction of autophagy however, evidence showed
that E1B19K does contribute to adenovirus-mediated autophagy by
interacting with Beclin1 and excluding BCL-2 from the PI3K-CIII-Beclin 1
interactome. Examination of the cellular pathways proved more promising
in understanding the regulation of autophagy during adenovirus mediated
autophagy.

The classical starvation pathway of autophagy induction,

AKT/mTOR, does not seem to play a role in adenovirus-mediated
autophagy.

However, the intracellular amino acid sensing pathway,

GCN2/eIF2α, is required for adenovirus mediated autophagy.

Cells

lacking GCN2 fail to undergo autophagy after adenovirus infection and are
more viable in vitro. On the other hand, in the in vivo setting GCN2
deficient mice are unable to cope with viral infection and their livers
undergo more cell death. We used this idea of autophagy and cell death
and examined the role of autophagic cell death and lysis. We found that
cells unable to undergo autophagy through chemical inhibition or deletion
99

of crucial autophagy genes had impaired lysis; while cells that had
increased autophagy flux through chemical manipulation underwent more
autophagy.
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Chapter 5
Discussion
The relationship between adenovirus and autophagy is relatively
unexplored compared with that between other viruses and autophagy.

Most

papers have only reported that autophagy coexists in a cell infected with
adenovirus or in conjunction with a therapeutic treatment (13, 27-30, 101).
However, we believe that our results provide insight into the role of autophagy
during adenovirus infections. Previous studies have shown that adenoviruses
induce autophagy (13, 27-30, 101, 102); however, only LC3 conversion and
increased Atg5/12 have been identified as biochemical markers. In this study,
we validated the changes in p62 observed in other autophagy studies (18); these
changes may be useful as biochemical markers for autophagy during adenoviral
infections (69). This addition to the overall studies with adenovirus and
autophagy are beneficial because p62 degradation and addition of Bafilomycin A
(103) can be used to monitor autophagy flux (11).

Therefore the functional

output of autophagy can be studied.
We began our studies examining whether infection alone was sufficient to
induce autophagy. We proposed that adenovirus replication induces a hyper
anabolic state the consumes large amounts of ATP and amino acids (32). We
found that infection alone was not sufficient to induce autophagy, therefore there
must be role viral proteins play or the act of replication itself that induces
autophagy. To identify the specific role each early gene played we infected cells
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deleted with each early gene. Of the early genes tested we were not able to
definitively prove that loss of these proteins was responsible for autophagy
induction. No virus was completely devoid of the induction of autophagy. Some
viruses were attenuated, for example E1B19K, but the only virus that had a
complete ablation of autophagy was the Delta-E1 virus, lacking E1A. The caveat
is that a virus deleted for E1A is also replication deficient. Therefore we cannot
separate the function of E1A for the cause of replication or its functions in
inducing autophagy. Exogenous restoration of E1A failed to induce autophagy,
however this is a very artificial way to attempt to replicate the role of E1A within
the cell. It is possible that E1A corroborates with other viral proteins to exert its
full function (47, 104). We believe further studies are needed that are able to
examine the role E1A plays specifically in the context of autophagy induction.
Because of the attenuated autophagy induction we decided to delve into
the viral protein-cellular protein interaction of E1B19K and Beclin 1. Yeast two
hybrid screens had never shown E1B19K to interact with Beclin 1 (105). This is
the first time that E1B19K has been shown to associate in a complex with Beclin
1.

Beclin 1 is a positive regulator of autophagy.

We found that Beclin 1,

E1B19K, and PI3K CIII all associate in a complex and remove BCL2 to induce
autophagy.

It is possible that E1B19K stabilizes the complex to promote

autophagy or E1B19K is involved in competitive binding with BCL2 to bind to
Beclin 1.
Although no single early gene appears to be required for autophagy
induction we cannot rule out the interplay of two or more early genes to exert a
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cellular function (47, 106). Therefore further studies with the deletion of two or
more viral proteins need to be done to fully examine the role viral proteins play in
adenovirus-mediated autophagy.
We also monitored the intracellular status of the cells to identify any
changes that were related to autophagy pathways. We proposed that the cells
are in a hyperanabolic status during virus infection and we did, in fact, find a
significant decrease in ATP. However, upon examination of the kinases that
sense and regulate ATP levels we found no involvement in autophagy regulation
during virus infection. The lack of involvement of LKB1 and AMPK in autophagy
regulation could be because their function is regulating protein translation during
virus infection.
The downstream effector in the AMPK pathway is mTOR (reviewed by
(107)). mTOR is primarily known as a monitor of cell growth by controlling S6K1
and 4E-BP1, and by regulating autophagy though via interaction with ULK1 (69).
mTOR is activated by growth factors, AKT, and AMPK (reviewed by (107)).
Generally speaking, autophagy is primarily known to be triggered through the
AKT/PDK1/mTOR pathway (3). We analyzed TSC2 within this pathway and did
not find a requirement of TSC2 in adenovirus-mediated autophagy. We also did
not find the mTOR was inhibited during virus infection. We found that AKT was
only fully activated at 48 hours post infection. Carloni et al reported an mTOR
feedback loop activation of AKT in the presence of growth factor receptor
stimulation(108) which is relevant to virus infection because O’Shea et al 2005
reported that adenovirus mimics growth factor signals to activated mTOR (53,
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109, 110).

We also found that p70S6K was phosphorylated throughout the

experiment and this

contradicts the

phosphorylation status of

mTOR.

Nonetheless, it has been reported that E1A regulates phosphorylation of S6K1
and 4E-BP1 independently of mTOR to facilitate viral replication (53, 111).
Therefore more information is needed to clarify the role of mTOR by coupling or
uncoupling the downstream substrates and identify their participation in protein
translation inhibition and autophagy induction. We believe that AKT pathway
activation is more involved in protein translation for productive viral replication
(53), however, these studies do not provide evidence for a role in the induction of
autophagy.

Further studies are warranted to understand the role of AKT

activation during adenovirus infection and the possibility of an mTOR
independent mechanism.
Basal levels of eIF2α phosphorylation under normal conditions is around
5-10% (82-84). 25% of eIF2a was phosphorylated in the late stage of adenovirus
infection (85). eIF2α activation, upon adenovirus infection, has historically been
attributed to PKR activation, despite the fact adenovirus employs VA RNA
against PKR, 25% of eIF2a remains phosphorylated. We propose that the
adenovirus neutralized PKR to inhibit an immune response, not to control
translation. In vitro phosphorylation assays revealed that activation of PKR and
subsequent phosphorylation of PKR are not sufficient to halt protein translation,
suggesting another alternative motive (85). We too saw an increase in eIF2a
phosphorylation and hypothesize that the purpose is to regulate autophagy.
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Previous studies have described the relationship between herpes viruses
and the regulation of autophagy through eIF2α pathway (66). Tallóczy et al
reported the GCN2 and PKR play roles in starvation and virus induced
autophagy, respectively (66). Since PKR does not play a role in eIF2a regulation
during adenovirus infection we chose not to examine PKR in autophagy
induction. Kouroku et at 2006 identified that polyQ overexpression lead to
increase of LC3 conversion and was ablated in eIF2α S51A Mefs and Atg5 KO
MEFs along with an increase in ATG5/12 (67). We also saw similar increase in
LC3 conversion and ATG5/12 increase during adenovirus infection (13).
However, we saw an unexpected decrease in the PERK-regulated chaperone
folding proteins, if the cell were under ER stress we would expect the levels of
expression to increase. Therefore GCN2 seemed to be the prime candidate of
examination.
We noted that cells lacking GCN2 were rendered resistant to the
cytopathic effect of the virus and these cells were unable to undergo autophagy.
We believed that the cells infected with adenovirus consumed large amounts of
amino acids and the cell was able to activated GCN2 to respond to the decline in
free amino acids, however when GCN2 is ablated, the cell has an impaired ability
to sense the amino acids and fails to induce autophagy therefore impairing viral
production.

Mice deficient for GCN2 fail to undergo autophagy in the liver

suggesting that GCN2 does play a role in autophagy regulation during in vivo
viral life cycle. We were surprised to see that the livers in GCN2 null mice
underwent twice the amount of cell death in vivo and correlated with decreased
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viability. We believe that autophagy is a protective mechanism and when the
cells were not able to undergo autophagy in the in vivo niche the hepatocytes
died by necrosis.
Neither our studies, nor Tallóczy et al and Kouroku et al, identified a
complete mechanism of the role eIF2α plays in the induction of autophagy (66,
67). A complete study of the eIF2α pathway is needed to isolate its involvement
in adenovirus-mediated autophagy. We believe the experiments here provide
evidence for a role of GCN2 during adenovirus infection. However, more
experiments are needed to identify the interplay between GCN2 and the
autophagy pathway. GCN2 has been implicated during infection with Sindbis
virus where GCN2 serves as an inhibitory molecule of viral replication by
blocking viral translation during infection (86). They attributed this to the
increased phosphorylation of eIF2α, however no downstream effectors were
analyzed. Ryzmski et al 2010 reported that bortezomib induces ER-stress and
induces autophagy through an eIF2a/ATF4 dependent mechanism (87).
Activating transcription factor 4 (ATF4) binds the cyclic AMP response element
binding domain of LC3, leading to transcriptional upregulation (87, 88). The ATF4
binding partner CHOP has been shown to bind and upregulate ATG5 (88).
However, our transcriptional activation studies have not shown any increase in
ATG5 or LC3 after virus infection (data not shown). We postulate this could be
due to the short turnover of the mRNAs, therefore an accumulation of mRNA is
difficult to identify.
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The relationship between autophagy and adenovirus-mediated cell lysis
has yet to be fully examined. We speculate that the generation of vacuoles in the
cytoplasm destroys the intracellular and membrane integrity of the cell facilitating
breakage of the membrane to aid in viral lysis. Here, for the first time, we show
that autophagy plays an essential role in the process of cell lysis induced by
adenovirus.
In the past there are three main viral proteins that have been the focus of
mediating viral cell lysis. The L3 viral protease cleaves cytokeratin K18 and
promoting lysis . There are a few reports suggesting that viral proteins regulate
the cell lysis process (112). The E3 11.6-kD adenovirus death protein (ADP),
aids in the destruction of the nuclear membrane and release of progeny virions
(50, 51). Overexpression of ADP was shown to increase oncolysis by
adenoviruses (113). It is unknown whether these two proteins play a role in the
regulation of autophagy.
Nevertheless, our data clearly demonstrate that autophagy plays an
essential role in adenovirus-mediated cell lysis. Treatment of cells with
autophagy inducers increases the size of plaques which one can attribute to cell
lysis, while treatment with 3-MA, an autophagy inhibitor, decreases the area of
plaques. Consistent with the above observations, knockout or downmodulation
of the key autophagy gene ATG5 substantially impairs the ability of the virus to
induce lysis of host cells. Thus, there is a cause-and-effect relationship between
autophagy and cell lysis. This suggests that autophagy, a highly genetically
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programmed cellular process, is a candidate target whose manipulation might
improve the efficiency of oncolytic adenovirus to induce lysis in cancer cells.
Our results here also provide a mechanistic rationale for our previous
reports showing that rapamycin has a synergistic effect with oncolytic
adenoviruses and strongly suggest that rapamycin-enhanced oncolytic potency is
due to facilitation of autophagy (28). These findings offer a rationale for the
combination of autophagy inducing drugs and oncolytic adenoviruses to enhance
glioma treatment.

In this regard, the gold standard for glioma treatment,

temozolomide, induces autophagy and has synergistic effects with oncolytic
adenoviruses (27).
In summary, we demonstrate here that GCN2 plays a significant role in
the regulation of adenovirus-mediated autophagy and that autophagy plays an
indispensable role in adenovirus-mediated cell lysis. Our study provides a new
mechanism for adenovirus-induced cell lysis through which strategies can be
imposed to improve oncolytic adenoviral potency in cancer therapy.
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